Clinical and biological relevance of glial fibrillary acidic protein in Alzheimer’s disease

Clinical and biological relevance of glial fibrillary acidic protein in Alzheimer’s disease

Abstract Introduction There is a tremendous need for identifying reliable blood-based biomarkers for Alzheimer’s disease (AD) that are tied to the biological ATN (amyloid, tau and neurodegeneration) framework as well as clinical assessment and progression. Methods One hundred forty-four elderly part...

Full description

Bibliographic Details
Main Authors: Zhengshi Yang, Karthik Sreenivasan, Erin N. Toledano Strom, Amanda M. Leisgang Osse, Lorenzo Gabriel Pasia, Celica Glenn Cosme, Maya Rae N. Mugosa, Emma Léa Chevalier, Aaron Ritter, Justin B. Miller, Dietmar Cordes, Jeffrey L. Cummings, Jefferson W. Kinney
Format: Article
Language:English
Published: BMC 2023-11-01
Series:Alzheimer’s Research & Therapy
Subjects:
Glial fibrillary acidic protein
Alzheimer’s disease
Ptau-181
ATN framework
18F-AV45
Online Access:https://doi.org/10.1186/s13195-023-01340-4

Internet

https://doi.org/10.1186/s13195-023-01340-4

Similar Items